Alnylam Pharmaceuticals | ALNY - Kapitał Akcyjny





Kapitał Akcyjny Zmiana Data
Acadia Pharmaceuticals USD 172.31M 174K 2026-09
Agios Pharmaceuticals USD 59.6M 264K 2026-06
Alnylam Pharmaceuticals USD 133.88M 141K 2026-09
Amgen USD 541M 0 2026-09
Arrowhead Research USD 141.14M 564K 2026-06
BioCryst Pharmaceuticals USD 255.26M 42.2M 2026-06
BioMarin Pharmaceutical USD 193.54M 267K 2026-06
Incyte USD 200.98M 1.03M 2026-06
Ionis Pharmaceuticals USD 165.64M 265K 2026-06
Moderna USD 391M 2M 2025-09
Neurocrine Biosciences USD 101.3M 750K 2026-09
Novartis USD 1.89B 19.47M 2026-09
PTC Therapeutics USD 83.33M 445K 2026-06
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Sanofi EUR 1.2B 2.15M 2026-06
Sarepta Therapeutics USD 107.23M 1.61M 2026-09
Takeda JPY 1.58B 460K 2026-06
Tectonic Therapeutic USD 19.24M 404.78K 2026-06
Ultragenyx Pharmaceutical USD 98.6M 300K 2026-06
Vertex Pharmaceuticals USD 253.5M 200K 2026-09
Xencor USD 74.33M 265K 2026-06